Orthocell Ltd (OCC)

Sydney
0.495
+0.010(+2.06%)
  • Volume:
    87,254
  • Bid/Ask:
    0.485/0.495
  • Day's Range:
    0.490 - 0.495

OCC Overview

Prev. Close
0.485
Day's Range
0.49-0.495
Revenue
1.65M
Open
0.49
52 wk Range
0.32-0.655
EPS
-0.05
Volume
87,254
Market Cap
92.89M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
350,805
P/E Ratio
-
Beta
1.44
1-Year Change
16.67%
Shares Outstanding
191,524,295
Next Earnings Date
-
What is your sentiment on Orthocell Ltd?
or
Market is currently closed. Voting is open during market hours.

Orthocell Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyNeutral
SummaryStrong BuyStrong BuyStrong BuyBuyNeutral

Orthocell Ltd Company Profile

Orthocell Ltd Company Profile

Employees
0
Market
Australia

Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair and regeneration of human tendon, bone, nerve, and cartilage defects in Australia and internationally. The company’s principal products include CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of tendons, peripheral nerves, bones, and articular cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation for the treatment of symptomatic defects of the articulating cartilage of the joints, primarily in the knee and ankle. In addition, the company develops Striate+ for use in bone and soft tissue repair; SMRT Graft for use in to augment repair of rotator cuff tendinopathy and tear; and Remplir, a nerve wrap. Orthocell Limited was incorporated in 2006 and is based in Murdoch, Australia.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.